Apeiron Presight Capital Fund II, L.P. 4
4 · BIONOMICS LTD/ADR · Filed Oct 7, 2024
Insider Transaction Report
Form 4
Apeiron Investment Group Ltd.
10% Owner
Transactions
- Sale
Ordinary Shares
2024-10-03$0.29/sh−180,707$52,405→ 93,469,320 total(indirect: By Apeiron Presight Capital Fund II, L.P.) - Sale
Ordinary Shares
2024-10-02$0.33/sh−90,806$29,966→ 125,996,580 total(indirect: By Apeiron Presight Capital Fund II, L.P.) - Sale
Ordinary Shares
2024-10-04$0.28/sh−557$156→ 93,369,060 total(indirect: By Apeiron Presight Capital Fund II, L.P.)
Holdings
- 183,121,441(indirect: By Apeiron Investment Group Ltd.)
Ordinary Shares
Footnotes (3)
- [F1]Includes Ordinary Shares represented by American Depositary Shares.
- [F2]The reportable securities are held by Apeiron Presight Capital Fund II, L.P. ("Apeiron Presight"). Apeiron Investment Group Ltd. ("Apeiron") and Fabian Hansen are the managing members of Presight Capital Management I, L.L.C. ("Presight Management"), which is the general partner of Apeiron Presight. As a result, each of Apeiron, Mr. Hansen and Presight Management may be deemed to share beneficial ownership of the securities.
- [F3]The reportable securities are held by Apeiron. Christian Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities.